We are live on
!
Find out more
Jazz Pharmaceuticals
JAZZ
JAZZ
570 hedge funds and large institutions have $12.3B invested in Jazz Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 89 funds opening new positions, 226 increasing their positions, 163 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
39% more repeat investments, than reductions
Existing positions increased: 226 | Existing positions reduced: 163
24% more call options, than puts
Call options by funds: $59.1M | Put options by funds: $47.6M
17% more capital invested
Capital invested by funds: $10.5B → $12.3B (+$1.8B)
14% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 78
4.06% more ownership
Funds ownership: 101.57% → 105.63% (+4.1%)
1% less funds holding
Funds holding: 573 → 570 (-3)
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
Holders
570
Holders Change
-3
Holders Change %
-0.52%
% of All Funds
7.02%
Holding in Top 10
13
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-13.33%
% of All Funds
0.16%
New
89
Increased
226
Reduced
163
Closed
78
Calls
$59.1M
Puts
$47.6M
Net Calls
+$11.5M
Net Calls Change
-$111M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$258M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$166M |
| 3 |
Bank of New York Mellon
New York
|
+$90.4M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$80.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$60.4M |
